What Happened to Cerevel Therapeutics Holdings?
Return
0.0%
Current Price
â
Peak Price
â
Trust Size
$1.1B
Summary
Cerevel Therapeutics Holdings, Inc. filed its S-1 registration in 2020 and completed its business combination in 2024. The company was delisted from exchanges with 448 SEC filings on record.
What Happened
Cerevel Therapeutics Holdings, Inc. entered the SPAC market in 2020 with its initial S-1 filing with the SEC, joining the wave of blank check companies seeking acquisition targets.
The company filed a definitive proxy statement (DEFM14A) ahead of its merger vote, completing its de-SPAC transaction in 2024.
SEC records show 448 total filings, including annual (10-K) and quarterly (10-Q) financial reports.
The company's last SEC filing was 2024-08-12, and it appears to have been delisted from exchanges â a common fate for SPACs that fail to meet listing requirements or generate sufficient shareholder interest.
The company was incorporated in Delaware, the preferred jurisdiction for the vast majority of SPACs due to its business-friendly legal framework.
Timeline
2020-05-29
S-1 Registration Filed
2024-01-18
Merger Proxy Filed (DEFM14A)
2024-08-12
Last SEC Filing